ANCA-ASSOCIATED VASCULITIS
Clinical trials for ANCA-ASSOCIATED VASCULITIS explained in plain language.
Never miss a new study
Get alerted when new ANCA-ASSOCIATED VASCULITIS trials appear
Sign up with your email to follow new studies for ANCA-ASSOCIATED VASCULITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Off-the-Shelf CAR-Ts take on lupus and more
Disease control Not yet recruitingThis early-phase study tests a universal (off-the-shelf) CAR-T cell therapy called RD06-05 in 30 people with active autoimmune diseases like lupus, scleroderma, vasculitis, myositis, or Sjögren's syndrome. The goal is to see if it is safe and can reduce disease activity by target…
Matched conditions: ANCA-ASSOCIATED VASCULITIS
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
Stem cell therapy takes on lupus and more
Disease control Not yet recruitingThis early-phase study tests BCT301, a therapy made from special stem cells turned into immune cells, for people with hard-to-treat autoimmune diseases like lupus and scleroderma. The main goal is to check safety and find the right dose. Only 10 participants will be enrolled.
Matched conditions: ANCA-ASSOCIATED VASCULITIS
Phase: EARLY_PHASE1 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
Scientists investigate faulty immune cells in autoimmune diseases
Knowledge-focused Not yet recruitingThis study aims to understand why certain immune cells (B cells) attack the body in autoimmune diseases like lupus and scleroderma. Researchers will analyze blood samples from 200 adults to identify and measure these harmful cells. The goal is to improve future treatments by targ…
Matched conditions: ANCA-ASSOCIATED VASCULITIS
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC